Chair of AusBiotech (WA Branch) named new PharmAust CEO
2 March 2016 via Biotech Dispatch: Dr Richard Hopkins, Chair of Ausbiotech (WA Branch), has been appointed to the role of Chief Executive Officer at PharmAust (ASX:PAA).
Dr Hopkins is an experienced pharmaceutical executive with over 10 years in corporate leadership roles. Most recently, he held the position of CEO of Phylogica Limited (ASX:PYC) from July 2013.
He has an established track record in development of novel cancer therapies with a particular focus on corporate strategy, business development and intellectual property.
The appointment will take effect from 7 March 2017.
Read more in Biotech Dispatch.